ELI LILLY & CO (LLY)
Clinical trial NCT03675893 updates: 1. enrollment: 180 → 110 participants 2. collaborators removed: Effector Therapeutics
Clinical trial NCT03675893 updates: 1. enrollment: 180 → 110 participants 2. collaborators removed: Effector Therapeutics
Clinical trial NCT07507708 updates: 1. status: WITHHELD → RECRUITING 2. start date: not set → 2026-05-14 3. completion date: not set → 2026-12-31 4. primary completion date: not set → 2026-12-31 5. enrollment: not set → 20 participants 6. study type: not set → INTERVENTIONAL 7. enrollment type: not set …
Clinical trial NCT07366086 updates: 1. completion date: 2028-05-21 → 2028-04-19 2. primary completion date: 2028-05-21 → 2028-04-19
Clinical trial NCT06291376 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 510 → 579 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05852054 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-01-31 → 2025-10-31 3. primary completion date: 2025-09-01 → 2024-10-31 4. enrollment: 1500 → 12 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07610278 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-03 → 2026-05-29
Clinical trial NCT07464314 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 225 → 1475 participants
Clinical trial NCT07518459 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-28 → 2026-05-26 3. primary completion date: 2026-05-28 → 2026-05-26 4. enrollment: 8 → 16 participants
Clinical trial NCT07042945 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-17 → 2026-06-05 3. primary completion date: 2026-07-08 → 2026-06-05 4. enrollment: 28 → 15 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT03651128 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-04-08 → 2026-04-13 3. primary completion date: 2027-04-08 → 2026-04-13 4. enrollment: 381 → 386 participants